Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Bio-heart Biological Technology Co., Ltd. is set to hold a pivotal board meeting on August 19, 2024, to review its first-half financial results and consider the issuance of an interim dividend. The announcement, made by Chairman Philip Li Wang, indicates a significant date for investors tracking the company’s performance and potential returns. This development could impact the company’s stock, traded under the code 2185.
For further insights into HK:2185 stock, check out TipRanks’ Stock Analysis page.